Angiodynamics to participate in the ubs global healthcare conference

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced, that jim clemmer, president and chief executive officer, and stephen trowbridge, executive vice president and chief financial officer, will participate in a fireside chat at the ubs global healthcare conference at 8:00 a.m. et on monday, nov.
ANGO Ratings Summary
ANGO Quant Ranking